Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

DNA technology provides novel strategy for delivery of complex anti-HIV agent

Editor's pick
Science Daily
6 September 2018
New & experimental HIV treatments

Elpida™ Included in Essential Drugs List for HIV-1 in Russia

Editor's pick
PR Newswire (press release)
6 September 2018
Treatment guidelines

Focus on HIV-2 Infection: A Clinician Roundtable

Editor's pick
Infectious Disease Advisor
4 September 2018
Pharmaceutical industry

Chasing top HIV players, Merck scores FDA approval for 2 new drugs

Editor's pick
FiercePharma
1 September 2018
New & experimental HIV treatments

FDA Approves Pair of HIV-1 Once-Daily Therapies from Merck

Editor's pick
MD Magazine
30 August 2018
Treatment simplification strategies

What you need to know about HIV two-drug regimens

Editor's pick
BETA blog
28 August 2018
New & experimental HIV treatments

HIV RNA expression inhibitors may restore immune function in HIV-infected individuals

Editor's pick
Science Daily
28 August 2018
People with limited treatment options

Ibalizumab Provides New Option for Patients with Multidrug-Resistant HIV

Editor's pick
MD Magazine
23 August 2018
Injectable & long-acting HIV treatment

Swapping daily pills for monthly shots could transform HIV treatment and prevention

Editor's pick
Science
23 August 2018
Treatment guidelines

Why the world may force women to choose: No birth control, no ARVs

Editor's pick
Bhekisisa
22 August 2018
Cardiovascular disease

Many people take drugs that interfere with their blood pressure pills

Editor's pick
Reuters
22 August 2018
TB treatment

How smartphones are becoming a weapon in the global fight against tuberculosis

Editor's pick
STAT
21 August 2018
New & experimental HIV treatments

New HIV therapy reduces virus, boosts immunity in drug-resistant patients

Editor's pick
Science Daily
16 August 2018
New & experimental HIV treatments

Should Gilead Be Worried About This New Monthly HIV Medication?

Editor's pick
Motley Fool
16 August 2018
PrEP

HIV drug research in Wales to cut infection risk

Editor's pick
BBC
16 August 2018
New & experimental HIV treatments

ViiV, Janssen’s two-drug HIV regimen hits PhIII targets

Editor's pick
Pharma Times
15 August 2018
Treatment for women

Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant

Editor's pick
The Body PRO
15 August 2018
New & experimental HIV treatments

How Will Long-Acting HIV Antiretrovirals Work in the Real World?

Editor's pick
The Body Pro
1 August 2018
Undetectable viral load & treatment as prevention

Australian doctors to tell HIV patients that 'undetectable=untransmissible'

Editor's pick
Gay Star News
24 July 2018
New & experimental HIV treatments

The 2018 Pipeline Report

Editor's pick
TAG
24 July 2018
HIV treatment

Benefits, Risks of Dolutegravir Center Stage at AIDS 2018

Editor's pick
Medscape (requires free registration)
18 July 2018
New & experimental HIV treatments

FDA approves Janssen's HIV combination Symtuza

Editor's pick
Pharmaphorum
18 July 2018
Drug interactions & pharmacokinetics

Darunavir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1

Editor's pick
MHRA
18 July 2018
Pharmaceutical industry

Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug

Editor's pick
Seeking Alpha
18 July 2018